Pyrrolidine → 5-(4-bromophenyl)-5-(2-oxo-2-pyrrolidin-1-ylethyl)-5H-imidazo[2,1-a]isoindole
반응식
[CH:1]1[CH:6]=[N:5][C:4]2N(O)N=N[C:3]=2C=1.FC(F)(F)C([O-])=O.[Br:18][C:19]1[CH:24]=[CH:23][C:22]([C:25]2([CH2:37][C:38]([OH:40])=O)[C:33]3[C:28](=[CH:29][CH:30]=[CH:31][CH:32]=3)[C:27]3=[NH+:34][CH:35]=[CH:36][N:26]23)=[CH:21][CH:20]=1.CCN(C(C)C)C(C)C.N1CCCC1>CN(C=O)C.C(Cl)CCl>[Br:18][C:19]1[CH:20]=[CH:21][C:22]([C:25]2([CH2:37][C:38](=[O:40])[N:5]3[CH2:4][CH2:3][CH2:1][CH2:6]3)[C:33]3[C:28](=[CH:29][CH:30]=[CH:31][CH:32]=3)[C:27]3=[N:34][CH:35]=[CH:36][N:26]23)=[CH:23][CH:24]=1참가 물질
반응물 4
생성물 1
시약·촉매·용매 2
실험 절차
To a mixture of EDC (49.2 mg) and HOAT (17.5 mg) was added a solution of 5-(4-bromophenyl)-5-(carboxymethyl)-5H-imidazo[2,1-a]isoindol-1-ium trifluoroacetate (62 mg) and Hunig's base (0.134 mL) in DMF (1 mL) followed by pyrrolidine (22.8 mg). The reaction mixture was stirred overnight at room temperature and was then purified by reversed phase HPLC (21×100 mm Phenomenex Gemini, 15-70% MeCN/water containing 0.05% NH4OH over 20 min at 20 mL/min) to give title compound as a white solid. HRMS. Found, 422.0873; calcd for (M+H)+, 422.0863. 1H NMR (500 MHz, CDCl3): δ 7.84 (d, J=7.60 Hz, 1 H); 7.47 (d, J=1.30 Hz, 1 H); 7.42-7.39 (m, 3 H); 7.29-7.26 (m, 3 H); 6.91 (dd, J=21.03, 8.48 Hz, 2 H); 3.71 (d, J=16.82 Hz, 1 H); 3.42 (t, J=6.89 Hz, 2 H); 3.34 (dt, J=9.85, 6.85 Hz, 1 H); 3.18 (dt, J=9.89, 6.80 Hz, 1 H); 2.86 (d, J=16.81 Hz, 1 H); 1.95-1.79 (m, 4 H).
후처리
- customwas then purified by reversed phase HPLC (21×100 mm Phenomenex Gemini, 15-70% MeCN/water containing 0.05% NH4OH over 20 min at 20 mL/min)
출처 및 근거
- ORD 기록
- ord-6d64d62dbb1341fd91bfb24ba02aa77c
- 출처 데이터셋
- uspto-grants-2013_09
- 특허 번호
- US08541595B2
반응 노트
불러오는 중…